Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Biochemistry and Cell Biology

• Publication date

  2010-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biocel.2009.12.025PMID 20060929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

  2010cited by this paper
• Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2.

  2009cited by this paper
• Crystal Structure of the BARD1 Ankyrin Repeat Domain and Its Functional Consequences*♦

  2008cited by this paper
• Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones

  2008cited by this paper
• Oncogenic BARD1 isoforms expressed in gynecological cancers.

  2007cited by this paper
• Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.

  2007cited by this paper
• Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase

  2007cited by this paper
• BARD1 Translocation to Mitochondria Correlates with Bax Oligomerization, Loss of Mitochondrial Membrane Potential, and Apoptosis*

  2007cited by this paper
• Estrogen receptor alpha regulates expression of the breast cancer 1 associated ring domain 1 (BARD1) gene through intronic DNA sequence.

  2007cited by this paper
• Is there more to BARD1 than BRCA1?

  2006cited by this paper
• Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis

  2006cited by this paper
• A truncated splice variant of human BARD1 that lacks the RING finger and ankyrin repeats.

  2006cited by this paper
• BRCA1 Interacts with Poly(A)-binding Protein

  2006cited by this paper
• BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase

  2005cited by this paper
• Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1.

  2005cited by this paper
• BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.

  2005cited by this paper
• Nucleophosmin/B23 Is a Candidate Substrate for the BRCA1-BARD1 Ubiquitin Ligase*

  2004cited by this paper
• Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression*

  2004cited by this paper
• Role of direct interaction in BRCA1 inhibition of estrogen receptor activity

  2001cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter.

  2000cited by this paper
• Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

  1997cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper

• Germline BARD1 Mutation in High-Risk Chinese Breast and Ovarian Cancer Patients

  2025cites this paper
• Exploiting E3 ligases for lung cancer therapy: The promise of DCAF-PROTACs.

  2025cites this paper
• A New Class of BRCA1 Mimetics for ERα-Positive Breast Cancer Therapy: Design, Synthesis, In Silico Screening, In Vitro Assay, and Gene Expression Analysis

  2025cites this paper
• Targeting BARD1 suppresses a Myc-dependent transcriptional program and tumor growth in pancreatic ductal adenocarcinoma

  2025cites this paper
• BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma?

  2025cites this paper
• Phosphorylation of BRCA1 at serine 1387 plays a critical role in cathepsin S-mediated radiation resistance via BRCA1 degradation and BCL2 stabilization.

  2024cites this paper
• BARD1 mystery: tumor suppressors are cancer susceptibility genes

  2022cites this paper
• BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy.

  2022cites this paper
• TRIM proteins in breast cancer: Function and mechanism.

  2022cites this paper
• XAF1 destabilizes estrogen receptor α through the assembly of a BRCA1-mediated destruction complex and promotes estrogen-induced apoptosis

  2022cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α

  2021cites this paper
• 1 BARD 1 and breast cancer : the possibility of creating 2 screening tests and new preventive and therapeutic 3 pathways for predisposed women 4

  2020cites this paper
• The Function of BARD1 in Centrosome Regulation in Cooperation with BRCA1/OLA1/RACK1

  2020cites this paper
• Dual Modulators of p53 and Cyclin D in ER Alpha Signaling by Albumin Nanovectors Bearing Zinc Chaperones for ER Positive Breast Cancer Therapy.

  2020cites this paper
• BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women

  2020influential citation
• BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance

  2019cites this paper
• Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy

  2018cites this paper
• Dualistic Role of BARD1 in Cancer

  2017cites this paper
• Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability

  2016cites this paper
• New concepts on BARD1: Regulator of BRCA pathways and beyond.

  2016cites this paper
• Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer

  2016cites this paper
• BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatin.

  2016cites this paper
• Ubiquitylation of nuclear receptors: new linkages and therapeutic implications.

  2015cites this paper
• RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy

  2014cites this paper
• Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.

  2014cites this paper
• Alternative splicing in cancer: implications for biology and therapy

  2014cites this paper
• Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.

  2014cites this paper
• Award Number: W81XWH-11-1-0097 TITLE: The Role of Skp1-Cul1-F-box Ubiquitin Ligases in Src- Stimulated Estrogen Receptor Proteolysis and Estrogen Receptor Target Gene Expression PRINCIPAL INVESTIGATOR:

  2014cites this paper
• Biochemical characterization of the estrogen receptor alpha (ERalpha) coactivator E6-Ap, SKPp2 and FBXL6

  2014influential citation
• RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy

  2013cites this paper
• UCSD MOLECULE PAGES BARD1

  2013cites this paper
• Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy

  2013cites this paper
• Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy

  2013cites this paper
• Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome

  2012cites this paper
• Breast Cancer Risk and 6 q 22 . 33 : Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA 1 / 2

  2012cites this paper
• A guide for functional analysis of BRCA1 variants of uncertain significance

  2012cites this paper
• Therapeutics , Targets , and Chemical Biology Common Variation at BARD 1 Results in the Expression of an Oncogenic Isoform That In fl uences Neuroblastoma Susceptibility and Oncogenicity

  2012cites this paper
• ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression.

  2012cites this paper
• BARD1: An independent predictor of survival in non‐small cell lung cancer

  2012cites this paper
• Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

  2012influential citation
• Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

  2012cites this paper
• THE NRF-1/GABP/BRCA1 Transcriptional Network in Mammary Epithelial Differentiation

  2012cites this paper
• Substitution of aspartic acid with glutamic acid at position 67 of the BRCA1 RING domain retains ubiquitin ligase activity and zinc(II) binding with a reduced transition temperature

  2011cites this paper
• A DNA Repair Protein BRCA1 as a Potentially Molecular Target for the Anticancer Platinum Drug Cisplatin

  2011cites this paper
• Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers

  2011cites this paper
• The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells

  2011cites this paper
• Signaling functions of ubiquitin in the 17β-estradiol (E2):estrogen receptor (ER) α network.

  2011cites this paper
• A theory that explains the tissue specificity of BRCA1/2 related and other hereditary cancers

  2010cites this paper
• Thermodynamic study of the BRCT domain of BARD1 and its interaction with the -pSER-X-X-Phe- motif-containing BRIP1 peptide.

  2010cites this paper
• Inflammatory processes inordinately increase tissue specific cancer risks in carriers of mutations in BRCA1, BRCA2, ATM or Fanconi anemia genes

  2010cites this paper
• A theory for the tissue specificity of BRCA1/2 related and other hereditary cancers

  2010cites this paper
• Analyse de l'expression de BARD1 dans le cancer du poumon et le cancer colorectal

  2010influential citation